Rapidly Progressive Idiopathic Pyoderma Gangrenosum in a Pediatric Patient Successfully Treated With Infliximab.

Area of Science:

• Dermatology
• Pediatric Medicine
• Immunology

Background:

• Pyoderma gangrenosum (PG) is a rare, ulcerative skin disease with unknown causes.
• Pediatric cases of PG are infrequent, representing about 4% of all patients.
• Standard treatment involves topical and systemic corticosteroids, often leading to quick symptom relief.

Observation:

• This report details a rare case of rapidly progressing pediatric pyoderma gangrenosum.
• The inciting cause of the condition was unknown.
• The patient was an infant or child.

Findings:

• Initial treatment with corticosteroids proved insufficient for this rapidly progressive case.
• A multi-modal therapeutic approach was required.
• The treatment regimen included systemic and topical corticosteroids, high-dose infliximab, and colchicine.

Implications:

• This case underscores the potential need for advanced therapies in severe pediatric PG.
• Understanding the pathophysiology of pediatric PG may lead to more targeted treatments.
• Aggressive management strategies may be necessary for refractory or rapidly progressing pediatric skin disorders like PG.